B A Chabner

3.3k citations
45 papers · 2.7k · 1 hit paper · h-index 23

Impact in

  • Oncology top 2%
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
  • Toxicology top 2%

Papers in

    • Biochemical and Molecular Research 9
    • Enzyme function and inhibition 5
    • Cancer therapeutics and mechanisms 4
    • Cancer Treatment and Pharmacology 5
    • Colorectal Cancer Treatments and Studies 4

B A Chabner

43 papers receiving 2.6k citations

B A Chabner's Hit Papers

The National Cancer Institute: cancer drug discovery and development program. 1992 · 659 citations
6590+11+22Years since publication200400600

Peers

B A Chabner
Comparison fields: 5 of 111
  • Oncology 992
  • Toxicology 106
  • Hematology 238
  • Organic Chemistry 534
  • Pathology and Forensic Medicine 276
Replace Daniel Glaubiger with:
Daniel Glaubiger United States
John M. Venditti United States
Alain Gouyette France
William P. Tong United States
Karen R. Grotzinger United States
H. M. Pinedo Netherlands
L B Grochow United States
Giovanna Damia Italy
Harumi Iida Japan
Tomoko Oh‐hara Japan
B A Chabner relative to Daniel Glaubiger United States Daniel Glaubiger's profile →
Citations per field
00.5×2.6×
Daniel Glaubiger · 1×
Citations per year

Countries citing papers authored by B A Chabner

Since Specialization
Citations

This map shows the geographic impact of B A Chabner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B A Chabner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B A Chabner more than expected).

Fields of papers citing papers by B A Chabner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B A Chabner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B A Chabner. The network helps show where B A Chabner may publish in the future.

Co-authors

The 25 scholars most cited alongside B A Chabner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B A Chabner Line = papers co-authored together B A Chabner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The National Cancer Institute: cancer drug discovery and development program.
Hit paper breakdown →
1992659
2 1994346
3
Cancer chemotherapy and biological response modifiers annual
1987220
4
Potential roles for preclinical pharmacology in phase I clinical trials.
1986155
5 1971117
6
Prospective randomized evaluation of the role of limb-sparing surgery, radiation therapy, and adjuvant chemoimmunotherapy in the treatment of adult soft-tissue sarcomas.
1978109
7
Production and characterization of monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissue.
1991108
8 1975103
9 198391
10 197587
11 199579
12 197574
13 199160
14 197656
15 198055
16
Dose-dependent metabolism of methotrexate in man and rhesus monkeys.
197745
17 197139
18 198934
19 197332
20
Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputation.
197932

About B A Chabner

B A Chabner is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Hematology, having authored 45 papers that have together received 2.7k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (9 papers), Acute Lymphoblastic Leukemia research (6 papers), Cancer Treatment and Pharmacology (5 papers), Enzyme function and inhibition (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Cancer therapeutics and mechanisms (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Oncology (992 citations), Toxicology (106 citations), Hematology (238 citations), Organic Chemistry (534 citations) and Pathology and Forensic Medicine (276 citations). B A Chabner has collaborated with scholars based in United States, Malaysia and Ukraine. Frequent co-authors include Michael R. Grever, Saul A. Schepartz, Herbert M. Pinedo, Dario Livio Longo, Carmen J. Allegra, J C Drake, Joseph R. Bertino, Jerry L. McCullough, Jacques Jolivet and Bernard Fisher. Their work appears in journals such as Blood, Journal of Clinical Oncology, Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Annals of the New York Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact